Historical record - last NADAC effective date: 1/1/2018
Product Information
NITROSTAT 0.3 MG TABLET SL is a brand product labeled by Pfizer Inc., priced at $0.5513 per EA under NDC 00071041724. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on May 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/1
Manufacturer
Pfizer Inc.NDC
00071041724
Classification
Brand
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
1/1/2018
Active Ingredients
NITROGLYCERINApproval Type
New Drug (NDA)
FDA Application
NDA021134FDA Approved
5/1/2000
TE Code
AB
On Market Since
5/1/2000
Pharmacological Classes
Price Statistics
The NADAC for NITROSTAT 0.3 MG TABLET SL has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 215.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5513 per EA |
|---|---|
| All-time high | $0.5513 (Jan 16, 2019) |
| All-time low | $0.1748 (Nov 28, 2013) |
| Median price | $0.4210 |
| Average price | $0.3804 |
| Largest weekly change | +55.0% (Oct 7, 2015) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+215.3%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NITROSTAT 0.3 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for NITROSTAT 0.3 MG TABLET SL, manufactured by Pfizer Inc., is $0.5513 per EA (NDC 00071041724), effective Jan 16, 2019.
How has the price of NITROSTAT 0.3 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for NITROSTAT 0.3 MG TABLET SL has risen 215.3%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NITROSTAT 0.3 MG TABLET SL?
Since Nov 28, 2013, the NADAC for NITROSTAT 0.3 MG TABLET SL has ranged from a low of $0.1748 (Nov 28, 2013) to a high of $0.5513 (Jan 16, 2019), with a median of $0.4210 per EA.
Are there cheaper alternatives to NITROSTAT 0.3 MG TABLET SL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROGLYCERIN 0.3 MG TABLET SL, is $0.0619 per EA — about 89% below NITROSTAT 0.3 MG TABLET SL.
Who manufactures NITROSTAT 0.3 MG TABLET SL?
NITROSTAT 0.3 MG TABLET SL (NDC 00071041724) is labeled by Pfizer Inc., and CMS classifies it as a brand product.